May 26, 2026
Markets
Eli Lilly's $4 Billion Vaccine Strategy: A Game Changer for Investors?
Eli Lilly's $4 billion investment in vaccine development could reshape its future and diversify revenue streams.
By James McAllister
Dividends
Investing in Dividend Aristocrats: A Strategy for Market Volatility
Explore the resilience of dividend aristocrats like Amcor, Hormel Foods, and Realty Income in uncertain markets.
Catherine Walsh
Markets
Eli Lilly's Strategic Biotech Acquisitions to Enhance Vaccine Portfolio
Diana Kowalski
Economy
US Inflation Rate Hits 3.8%: Implications for Federal Reserve Policy
US inflation rises to 3.8% in April. What does this mean for the Federal Reserve's future policy decisions?
Tyler Brooks
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Markets
Cerrado Gold's Strategic Acquisition: Strengthening its Position in Argentina
James McAllister • May 26
Analysis
AvalonBay and Equity Residential: Impacts of Their All-Stock Merger on the REIT Landscape
Marcus Rivera • May 21
Markets
Parker Hannifin's $2.5B Acquisition: A Strategic Move in Aerospace and Defense
James McAllister • May 21
Economy
ZenaTech's Strategic Move: Acquiring Alberta Surveying Firm to Enhance Drone Services
Tyler Brooks • May 21
Markets
Devon Energy Strengthens Delaware Basin Portfolio with $2.6 Billion Acquisition
Diana Kowalski • May 21